Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Tandem Diabetes Data Shows Improved Quality of Life with Mobi Insulin Pump - Medical Product Outsourcing
OEM News

Tandem Diabetes Data Shows Improved Quality of Life with Mobi Insulin Pump

The survey found 86% of participants were satisfied or very satisfied with Mobi, regardless of prior therapy.

Tandem Diabetes Care shared real-world insights from a Tandem Mobi with Control-IQ user survey at the 84th Scientific Sessions of the American Diabetes Association (ADA).
 
The survey found 86% of participants were satisfied or very satisfied with Mobi, regardless of prior therapy. They also agreed that Mobi improved their quality of life.
 
Tandem Mobi was released in the U.S. in February 2024. According to the company, it’s the world’s smallest, durable automated insulin delivery (AID) system. Mobi’s integrated with Dexcom G7 and G6 continuous glucose monitoring (CGM) systems was also announced last month.
 
The six-week, limited launch survey targeted early users who were previously using multiple daily injections (MDI), other insulin pumps, or were previous Tandem pump users.
 
84% of prior MDI users said Mobi reduced the burden of managing diabetes. 82% said it was easy to use, and 77% said Mobi helped them feel they have more freedom in their lives.
 
78% of prior pump users said Mobi reduced their management burden. 88% said it was easy to use, and 80% said it helped them feel they had more freedom in their lives.
 
An independent study also shared at ADA showed time in range improved without an increase in time spent below range.
 
“These real-world user insights provide evidence that we are furthering our mission to improve the lives of people with diabetes by demonstrating that Tandem Mobi not only meets, but exceeds user expectations,” said Jordan Pinsker, MD, chief medical officer at Tandem Diabetes Care. “We are proud to share these results at ADA and will continue to innovate to provide the diabetes community with choice and improved quality of life.”

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters